Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist have?
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist has 48 citations in the OpenAlex counts ScholarIQ stores.
When was Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist published?
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist has 2011 year in the ScholarIQ index.
What is the open-access status of Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist?
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist has green oa status in the ScholarIQ index.
What is the DOI of Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist?
The DOI for Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist is on the source record.
What is the PMID of Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist?
The PMID for Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist is on the source record.
What is the OpenAlex record for Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist?
The OpenAlex for Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist is on the source record.